MANAGEMENT OF THROMBOCYTOPENIA AND FLU-LIKE SYMPTOMS IN DENGUE PATIENTS WITH HERBAL WATER OF EUPHORBIA HIRTA
AbstractBackground: Incidence of dengue increased 30 fold between 1960 and 2010. This increase isbelieved to be due to a combination of urbanisation, population growth, increased internationaltravel, and global warming. We tried to find out the effect of herbal water of Tawa-tawa, alsocalled Euphorbia hirta, on the flu like symptoms and blood parameters especially onthrombocytopenia. Methods: Total 125 patients with confirmed dengue fever admitted in medicalward of Sir Ganga Ram Hospital Lahore were included in this experimental study. Duration ofstudy was 3 months. Patients were divided into 2 groups, i.e., group A (ages between 30 to 55years) and group B (ages between 14 to 25 years). A blood sample was obtained on the day ofenrolment and after 24 hours of using Tawa-tawa. The variables used were platelet count,haematocrit (HCT), WBC count, serum AST, ALT, IgM/IgG. Results: In men, platelet count was<25,000 and in women, it was >50,000. Haematocrit were >40% in men and 30–40% in women.TLC in a range of 4,000–11,000/mm3 was observed in both males and females. IgM‘haemagglutination’ antibody titres (>1:160) was observed in 71.3% females and 50% males.Serum AST was >40 IU/L in 38% females and 36% males. Serum ALT was >40 IU/L in 9.5%females and 12% males. In both group A and B platelet count and TLC were increased nonsignificantly after herbal water of Euphorbia hirta (E. Hirta). Haematocrit value decreased nonsignificantly after using the herbal water. Over 70% of patients showed moderate increase in theirplatelet count. However leucopoenia improved significantly after the use of aqueous extract of E.hirta. A marked recovery in fever and flu like symptoms was observed. Conclusion: In over 70%patients there was improvement in platelet count, TLC, fever, and flue-like symptoms.Keywords: Dengue, Thrombocytopenia, Euphorbia hirta, Management
Chen R, Vasilakis N. Dengue –Quo tu et quo vadis? Viruses
Wilson N, Slaney D, Baker MG, Hales S, Britton E. Climate
change and infectious diseases in New Zealand: a brief review
and tentative research agenda. Rev Environ Health
Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine
Mahmood K, Jameel T, Aslam HF, Tahir M. Incidence of
dengue haemorrhagic fever in local population of Lahore,
Pakistan. Biomedica 2009;25:93–6.
Halstead SB. Pathogenesis of dengue: challenges to molecular
biology. Science 2009;239:476–81.
Smith DR. An update on mosquito cell expressed dengue virus
receptor proteins. Insect Mol Biol 2011;Sep 7. [Epub ahead of
Heaton NS, Randall G. Dengue virus and autophagy. Viruses
Potts JA, Gibbons RV, Rothman AL, Srikiatkhachorn A, Thomas
SJ, Supradish PO, et al. Prediction of Dengue Disease Severity
among Pediatric Thai Patients Using Early Clinical Laboratory
Indicators. PLoS Negl Trop Dis 2010;4(8):e769.
de Moura Mendonça LS, de Moura Mendonça ML, Parrode
N, Barbosa M, Cardoso RM, de Araújo-Filho JA. Splenic
rupture in dengue hemorrhagic fever: report of a case and review.
Jpn J Infect Dis 2011; 64(4):330–2.
Trung DT, Thao le TT, Hien TT, Hung NT, Vinh NN, Hien
, et al. Liver involvement associated with dengue infection in
adults in Vietnam. Am J Trop Med Hyg 2010;83(4):774–80.
Severson DW, Behura SK. Mosquito Genomics: Progress and
Challenges. Annu Rev Entomol 2010; Dec 15. [Epub ahead of
Kumar S, Malhotra R and Kumar D. Euphorbia hirta: Its
chemistry, traditional and medicinal uses, and pharmacological
activities. Pharmacognosy Review 2010;4(7):58–61.
Vijaya K, Ananthan S, Nalini R. Antibacterial effect of
theaflavin, polyphenon 60 (Camellia sinensis) and E. hirta on
Shigella spp. –a cell culture study. J Ethanopharmacol
Lopez HS, Luna TAMS, Manalo RE, Natividad JAJ, Ngo CY,
Apostol JG. A study on the platelet increasing activity of the
decoction and ethenolic extract of E. hirta as a treatment for
dengue hemorrhagic fever. J Phil Pharm Assoc 2009;2(1):16–23.
Prajapati ND, Purohit SS, Sharma AK, Kumar T. Handbook of
Medicinal Plants. Jodhpur, India: Agarbios 2003; p.120.
Khan E, Kisat M, Khan N, Nasir A, Ayub S, Hasan R.
Demographic and clinical features of dengue fever in Pakistan
from 2003–2007: a retrospective cross-sectional study. PLoS
Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki
H, Gjørup I, et al. European Network on Surveillance of
Imported infectious diseases. Severe dengue virus infection in
travelers: risk factors and laboratory indicators. J Infect Disease
Bottieau E, Clerinx J, Van den Enden E, Van Esbroeck
M, Colebunders R, Van Gompel A, et al. Fever after a stay in
the tropics: diagnostic predictors of the leading tropical
conditions. Medicine (Baltimore) 2007;86(1):18–25.
Chacko B, Subramanian G. Clinical, laboratory and radiological
parameters in children with dengue fever and predictive factors
for dengue shock syndrome. J Trop Pediatr 2008;54(2):137–40.
Quiroz E, Ortega M, Guzmán MG, Vázquez S, Pelegrino
JL, Campos C, et al. Dengue in Panama, 1993. Rev Cubana
Med Trop 1997;49(2):86–93. [Article in Spanish]
Srikiatkhachorn A, Green S. Markers of dengue disease severity
Curr Top Microbiol Immunol 2010;338:67–82.
Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis
Lanhers MC, Fleurentin J, DorfmanP, Mortier P, Pelt JM.
Analgesic, antipyretic and anti-inflammatory properties of
Euphorbia hirta. Planta Med 1991;57(3):225–31.
Chopra RN, Chopra IC, Handa KL, Kapur LD. Indigenous drugs
of India. Calcutta, India: Academic Publishers;1994.p. 88.
Jae-Ha R, Hanna A, Hwa Jin L, Wen He Q, Yong Nam H,
Byung Hoon H. Inhibitory activity of Chinese Medicinal plants
on Nitric oxide synthesis in Lipopolysaccharide activated
macrophages. J Appl Pharmacol 2007;9:183–7.
Rezaeipoor R, Saeidnia S, Kamalinejad M. Immuno suppressive
activity of Achillea talagonia on humoral immune responses in
experimental animals. J Ethanolpharmacol 1999;65;273–6.
Ramesh KV and Padmavathi K. Assessment of
immunomodulatory activity of Euphorbia hirta L. Indian J of
Pharmaceutical Sciences 2010;72(5)621–5.